Companies / Peru
If you would like to subscribe to Americas Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Americas Pharma & Healthcare Insight please click on the trial link below.
New Row Over Clinical Tests In Peru
July 2006 | Industry NewsSorry, you must be a subscriber to view this article in full. If you are a subscriber please login.
If you would like to subscribe to Americas Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Americas Pharma & Healthcare Insight please click on the trial link below.
Stakeholders in Peru's medical establishment have weighed in to a controversy over a clinical trial of a new treatment for infant diahorrea. The product - an oral rehydration solution synthesised from transgenic rice - was developed by US biotech Ventria. While gene therapy advocates have hailed the successful research as a breakthrough, dissident local medical groups claim that the tests were